Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.68 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.53 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.51 |
| ▸ | CSF1R | P07333 | 1/20 | 0.51 |
| ▸ | KDR | P35968 | 1/20 | 0.51 |
| ▸ | FLT3 | P36888 | 1/20 | 0.51 |
| ▸ | GSK3A | P49840 | 1/20 | 0.51 |
| ▸ | GSK3B | P49841 | 1/20 | 0.51 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.51 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.51 |
| ▸ | SLK | Q9H2G2 | 1/20 | 0.51 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.51 |
| ▸ | BRS3 | P32247 | 2/20 | 0.51 |
| ▸ | BDKRB1 | P46663 | 7/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.47 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29390423 | 1.00 | SLC6A3 (0.68) | SLC6A3SLC6A4SLC6A2LTB4R2ROCK2 | |
| SCHEMBL8670912 | 0.98 | SLC6A3 (0.66) | SLC6A3SLC6A4SLC6A2LTB4R2ROCK2 | |
| SCHEMBL8792048 | 0.88 | SLC6A3 (0.64) | SLC6A3SLC6A4SLC6A2LTB4R2ROCK2 | |
| SCHEMBL29979869 | 0.87 | SLC6A3 (0.69) | SLC6A3SLC6A4SLC6A2LTB4R2ROCK2 | |
| SCHEMBL3112718 | 0.87 | SLC6A3 (0.69) | SLC6A3SLC6A4SLC6A2LTB4R2ROCK2 | |
| SCHEMBL14326964 | 0.87 | SLC6A3 (0.69) | SLC6A3SLC6A4SLC6A2LTB4R2ROCK2 | |
| SCHEMBL2642187 | 0.86 | SLC6A3 (0.67) | SLC6A3SLC6A4SLC6A2LTB4R2ROCK2 | |
| SCHEMBL5863187 | 0.85 | TSHR (0.57) | SLC6A3SLC6A4LTB4R2KMT2ALMNA | |
| SCHEMBL5099361 | 0.85 | SLC6A3 (0.49) | SLC6A3SLC6A4SLC6A2LTB4R2ROCK2 | |
| SCHEMBL8916346 | 0.84 | SLC6A3 (0.48) | SLC6A3SLC6A4SLC6A2LTB4R2BRS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115959962-B | Visible light-promoted halogenated alkane hydrodehalogenation method | 中国科学院兰州化学物理研究所 | 2025-05-23 | — | — | CN | claimed |
| CN-114814041-B | Method for detecting brominated alkanes genotoxic impurities in telmisartan by adopting liquid chromatography-mass spectrometer | 浙江金立源药业有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117069580-B | Triclosan hapten as well as preparation method and application thereof | 北京市疾病预防控制中心 | 2024-02-23 | — | — | CN | claimed |
| CN-117510973-A | Lightweight PET decorative film and preparation process thereof | 江苏新光镭射包装材料股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-117069580-A | Triclosan hapten as well as preparation method and application thereof | 北京市疾病预防控制中心 | 2023-11-17 | — | — | CN | claimed |
| CN-116813512-B | Florfenicol hapten as well as preparation method and application thereof | 中国农业大学 | 2023-11-07 | — | — | CN | claimed |
| CN-116813512-A | Florfenicol hapten as well as preparation method and application thereof | 中国农业大学 | 2023-09-29 | — | — | CN | claimed |
| CN-110156761-B | Compound containing coumarin-biphenyl skeleton, preparation method and application thereof | 郑州大学 | 2022-08-09 | — | — | CN | claimed |
| CN-114814041-A | Method for detecting bromoalkane genotoxic impurities in telmisartan by adopting liquid chromatograph-mass spectrometer | 浙江金立源药业有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-113200934-B | Compound containing benzomorpholone-biphenyl skeleton and preparation method and application thereof | 郑州大学 | 2022-05-31 | — | — | CN | claimed |
| CN-110156761-A | Containing cumarin-biphenyl backbone compound, preparation method and applications | 郑州大学 | 2019-08-23 | — | — | CN | claimed |
| US-10077242-B2 | Convergent approach to the total synthesis of telmisartan via a suzuki cross-coupling reaction | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2018-09-18 | — | — | US | claimed |
| US-20170260146-A1 | A CONVERGENT APPROACH TO THE TOTAL SYNTHESIS OF TELMISARTAN VIA A SUZUKI CROSS-COUPLING REACTION | VIRGINIA COMMONWEALTH UNIVERSITY | 2017-09-14 | — | — | US | claimed |
| US-7943781-B2 | Process for preparing telmisartan | DR. REDDY'S LABORATORIES LIMITED (IN) | 2011-05-17 | — | — | US | claimed |
| EP-1805146-A4 | PROCESS FOR PREPARING TELMISARTAN | REDDYS LAB LTD DR (IN) | 2009-01-14 | — | — | EP | claimed |
| US-20070287840-A1 | Process for Preparing Telmisartan | DR. REDDY'S LABORATORIES LIMITED (IN) | 2007-12-13 | — | — | US | claimed |
| EP-1805146-A2 | PROCESS FOR PREPARING TELMISARTAN | Dr. Reddy's Laboratories Ltd. (IN) | 2007-07-11 | — | — | EP | claimed |
| US-20060211866-A1 | Process for the preparation of angiotensin receptor blockers and intermediates thereof | GLENMARK PHARMACEUTICALS LIMITED (IN) | 2006-09-21 | — | — | US | claimed |
| WO-2006044754-A2 | PROCESS FOR PREPARING TELMISARTAN | DR. REDDY'S LABORATORIES LTD. (IN) | 2006-04-27 | — | — | WO | claimed |
| EP-0527851-B1 | 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | SEARLE & CO (US) | 1998-12-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10077242-B2 | Convergent approach to the total synthesis of telmisartan via a suzuki cross-coupling reaction | AGTR2, AGTR1, REN | SLC6A3 1584/4885SLC6A4 1377/4885SLC6A2 1562/4885 |
| US-20060211866-A1 | Process for the preparation of angiotensin receptor blockers and intermediates thereof | AGTR1, AGTR2, BDKRB1 | SLC6A3 1210/4885SLC6A4 999/4885SLC6A2 1071/4885 |
| US-20070287840-A1 | Process for Preparing Telmisartan | AGT, TTR, REN | SLC6A3 3387/4885SLC6A4 1416/4885SLC6A2 2289/4885 |
| US-20170260146-A1 | A CONVERGENT APPROACH TO THE TOTAL SYNTHESIS OF TELMISARTAN VIA A SUZUKI CROSS-COUPLING REACTION | REN, AGTR1, AGTR2 | SLC6A3 1794/4885SLC6A4 1777/4885SLC6A2 1758/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.